Key Insights

Highlights

Success Rate

70% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

11.5%

3 terminated out of 26 trials

Success Rate

70.0%

-16.5% vs benchmark

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results70% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (5)
P 1 (2)
P 2 (7)
P 3 (1)
P 4 (2)

Trial Status

Unknown11
Completed7
Recruiting3
Terminated3
Active Not Recruiting1
Not Yet Recruiting1

Trial Success Rate

70.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT07030140Phase 2Recruiting

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

NCT07176962Recruiting

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

NCT07161869Not Yet RecruitingPrimary

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)

NCT05678218CompletedPrimary

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

NCT04561453Terminated

Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer

NCT05239169Phase 2Completed

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

NCT05551299Phase 4RecruitingPrimary

Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy

NCT06717464Phase 2Active Not Recruiting

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

NCT06106750Not ApplicableUnknown

Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent

NCT05626127UnknownPrimary

MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma

NCT04611100Not ApplicableCompletedPrimary

Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma

NCT04779788Not ApplicableUnknownPrimary

I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma

NCT03620292Phase 1UnknownPrimary

Fluorescence Image Guided Surgery in Cholangiocarcinoma

NCT02082522Phase 3TerminatedPrimary

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

NCT02108145Phase 2UnknownPrimary

Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma

NCT02955771Phase 2TerminatedPrimary

Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma

NCT03739164Unknown

Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)

NCT03132649UnknownPrimary

Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma

NCT03320980CompletedPrimary

RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma

NCT02801500Not ApplicableUnknownPrimary

Superior Bilioenteric Anastomosis by Magnetic Compressive Technique

Scroll to load more

Research Network

Activity Timeline